After the euphoria: HIV medical technologies from the perspective of their prescribers

Sociology of Health and Illness

Volumn 26, Issue 5, 2004, Pages 575-596

  Rosengarten, Marsha ^a,e   Imrie, John ^a   Flowers, Paul ^b   Davis, Mark D ^c   Hart, Graham J ^d  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b GLASGOW CALEDONIAN UNIVERSITY   (United Kingdom)

^c CITY UNIVERSITY   (United Kingdom)

^d UNIVERSITY OF GLASGOW   (United Kingdom)

^e UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Doctors patient relations; HIV antiretroviral combination therapy; Medical technologies

Indexed keywords

ARTICLE; DOCTOR PATIENT RELATION; EPIDEMIC; ETHICS; EUPHORIA; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IATROGENIC DISEASE; INFECTION RISK; MEDICAL PRACTICE; MEDICAL TECHNOLOGY; RISK ASSESSMENT; SOCIAL ASPECT; VIRUS RESISTANCE; ATTITUDE TO HEALTH; BIOMEDICAL TECHNOLOGY ASSESSMENT; CHEMICALLY INDUCED DISORDER; CLINICAL PRACTICE; DRUG MONITORING; DRUG UTILIZATION; FEMALE; HEALTH CARE PLANNING; HEALTH PERSONNEL ATTITUDE; HIV ASSOCIATED LIPODYSTROPHY; MALE; ORGANIZATION; ORGANIZATION AND MANAGEMENT; PHYSICIAN; PHYSICIAN ATTITUDE; PRESCRIPTION; PSYCHOLOGICAL ASPECT; QUESTIONNAIRE; UNITED KINGDOM; UTILIZATION REVIEW;

ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; ATTITUDE OF HEALTH PERSONNEL; ATTITUDE TO HEALTH; DRUG MONITORING; DRUG UTILIZATION; EUPHORIA; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEALTH RESOURCES; HIV INFECTIONS; HIV-ASSOCIATED LIPODYSTROPHY SYNDROME; HUMANS; LONDON; MALE; ORGANIZATIONAL INNOVATION; PHYSICIAN'S PRACTICE PATTERNS; PHYSICIAN'S ROLE; PHYSICIAN-PATIENT RELATIONS; PHYSICIANS; PRESCRIPTIONS, DRUG; QUESTIONNAIRES; TECHNOLOGY ASSESSMENT, BIOMEDICAL;

EID: 4143085217     PISSN: 01419889     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0141-9889.2004.00406.x     Document Type: Article

References (38)

1. Barad, K. (1998) Getting real: technoscientific practices and the materialization of reality, Differences: A Journal of Feminist Cultural Studies, 10, 2, 87-128.
2. Barroso, P.F., Schlechter, M., Gupta, P., Melo, M.F., Vieira, M., Murta, F.C., Souza, Y. and Harrison, L.H. (2000) Effect of antiretroviral therapy on HIV shedding in semen, Annals of Internal Medicine, 133, 4, 280-4.
3. Berg, M. (1992) The construction of medical disposals, medical sociology and medical problem solving in clinical practice, Sociology of Health and Illness, 14, 2, 151-80.
4. Bordo, S. (1988) Anorexia nervosa: psychopathology as the crystallization of culture. In Diamond, I. and Quinby, L. (eds) Feminism and Foucault: Reflections on Resistance. Boston: Northeastern University Press.
5. British HIV Association (BHIVA) (2001) Guidelines for the treatment of HIV-infected adults with antiretroviral therapy, HIV Medicine, 2, 276-313.
6. British Medical Journal (BMJ) (2003) 326, 31 May.
7. Callon, M., Meadel, C. and Rabeharisoa, V. (2002) The economy of qualities, Economy and Society, 31, 2, 194-217.
8. Chesney, M.A., Ickovics, J.R., Chambers, D.B., Gifford, A.L. et al. (2000) Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: the AACTG adherence instruments, AIDS Care, 12, 3, 255-66.
9. Davis, M.D., Hart, G.J., Imrie, J., Davidson, O., Williams, I. and Stephenson, J. (2002) 'HIV is HIV to me: the meanings of treatment, viral load and reinfection for gay men living with HIV, Health, Risk and Society, 4, 1, 31-43.
10. Flowers, P. (2001) Gay men and HIV/AIDS risk management, Health, 5, 50-75.
11. Fuqua, J.V. (2002) Ask your doctor about . . .': direct-to-consumer prescription drug advertising and the HIV/AIDS marketplace, Cultural Studies, 16, 5, 651-72.
12. Gerbert, B., Bronstone, A., Clanon, K. and Abercrombie, P. (2000) Combination antiretroviral therapy: health care providers confront emerging dilemmas, AIDS Care, 12, 4, 409-21.
13. Haraway, D. (1989) The biopolitics of postmodern bodies: determinations of self in immune system discourse, Differences, 1, Winter.
14. Ho, D.D. (1995) Time to hit HIV, early and hard, New England Journal of Medicine, 333, 7, 450-1.
15. International Collaboration on HIV Optimism (2003) HIV treatments optimism among gay men: an international perspective, JAIDS, 32, 545-50.
16. Kippax, S. and Race, K. (forthcoming 2003) Sustaining safe practice: twenty years on, Social Science and Medicine, 57, 1-12.
17. Marelich, W.D., Johnston Roberts, K., Murphy, D.A. and Callari, T. (2002) HIV/AIDS patient involvement in antiretroviral treatment decisions, AIDS CARE, 14, 1, 17-26.
18. Martin, E. (1990) Toward an anthropology of immunology: the body as nation state, Medical Anthropology Quarterly, 4, 4,
19. Moatti, J.P. and Souteyrand, A. (2000) Editorial: HIV/AIDS social and behavioural research: past advances and thoughts about the future, Social Science and Medicine, 50, 1519-32.
20. th Edition, London: BMJ Books.
21. Moore, A., Candlin, Christopher N. and Plum, G.A. (2001) Making sense of HIV-related viral load: one expert or two? Culture, Health and Sexuality, 3, 4, 429-50.
22. Novas, C. and Rose, N. (2000) Genetic risk and the birth of the somatic individual, Economy and Society, Special Issue on configurations of risk, 29, 4, 484-513.
23. Palella, F.J., Dalaney, K.M., Moorman, A.C. et al. (1998) Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection, New England Journal of Medicine, 338, 853-60.
24. Persson, A. (2003) Health (dis)figures: HIV, medicine, and body shape change. Paper presented at Body Modifications: Changing Bodies, Changing Selves, Macquarie University, 24-26 April 2003.
25. Persson, A., Race, K. and Wakeford, E. (2003) HIV health in context: negotiating medical technology and lived experience, Health, 7, 4, 397-415.
26. Power, R., Tate, L., McGill, S. and Taylor, C. (2003) A qualitative study of the psychosocial implications of lipodystrophy syndrome on HIV positive individuals, Sexually Transmitted Infections, 79, 137-41.
27. Quinn, T.C., Wawer, M.J., Sewankambo, N., Serwadda, D., Li Chuanjun, Wabwire-Mangen, F., Meehan, M.O., Lutalo, T. and Gray, R.H. (2000) Viral load and heterosexual transmission of human immunodeficiency virus type I, New England Journal of Medicine, 342, 921-9.
28. Race, K. (2001) The undetectable crisis: changing technologies of risk, Sexualities, 4, 2, 167-89.
29. Race, K., McInnes, D., Wakeford, E., Kleinhert, V., McMurchie, M. and Kidd, M. (2001) Adherence and communication: reports from a study of HIV general practice, Monograph 8/2001 National Centre in HIV Social Research, Sydney.
30. Rosengarten, M. (2002) 'The virus you get this year is not the virus you got 10 years ago' (London clinician): HIV as active 'literate' matter, mediation and medical intervention, Bios: Research Group on Social and Ethical Aspects of the Life Sciences, Biomedicine and the Life Course, Goldsmiths, University of London, 21 March.
31. Rosengarten, M. (2004) Consumer activism in HIV pharmacology, Body and Society, 10, 1, 91-107.
32. Rosengarten, M., Race, K. and Kippax, S. (2000) 'Touch wood, everything will be ok': gay men's understandings of clinical markers in sexual practice, Monograph 7/2000 National Centre in HIV Social Research, Sydney.
33. Schapiro, J. (2001) Understanding Protease Inhibitor potency: The intersection of exposure, efficacy, and resistance, The AIDS Reader, 11, 6, 311-15.
34. Strauss, A. and Corbin, J. (1998) Basics of Qualitative Research: Techniques and Procedures for Developing Grounded Theory. Thousand Oaks: Sage Publications.
35. Treichler, P. (1988) AIDS, gender, and biomedical discourse: current contests for meaning. In Free, E. and Fox, D.M. (eds) AIDS: The Burden of History. Berkeley: University of California Press.
36. Wagner, G. (2003) Does discontinuing the use of pill boxes to facilitate electronic monitoring impede adherence? International Journal of STD and AIDS, 14, 1, 64-5.
37. Webster, A. (2002) Innovative health technologies and the social: redefining health, medicine and the body, Current Sociology, 50, 3, 443-57.
38. Yallop, S., Lowth, A., Fitzgerald, M.H., Reid, J. and Morelli, A. (2002) The changing world of HIV care: the impact on health professionals, Culture, Health and Sexuality, 4, 4, 431-41.